New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 7, 2013
10:01 EDTMLNX, FIO, ABBV, PFE, SYRG, VRTX, VCLK, RBCN, TRLA, OPTR, FLY, DLA, GOOGOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Delta Apparel (DLA) initiated with a Buy at Roth Capital... Fly Leasing (FLY) initiated with a Buy at Deutsche Bank... Google (GOOG) initiated with a Neutral at Sterne Agee... Optimer (OPTR) initiated with an Outperform at RW Baird... Trulia (TRLA) initiated with a Neutral at Goldman... ValueClick (VCLK) initiated with a Buy at Goldman... Vertex (VRTX) initiated with an Outperform at RW Baird... Rubicon (RBCN) coverage resumed with an Underweight at Piper Jaffray... Synergy Resources (SYRG) initiated with a Buy at Canaccord... Pfizer (PFE) reinstated with a Neutral at Credit Suisse... AbbVie (ABBV) initiated with a Neutral at Credit Suisse... Fusion-io (FIO) initiated with a Neutral at Janney Capital... Mellanox (MLNX) initiated with a Buy at Janney Capital.
News For GOOG;DLA;FLY;OPTR;TRLA;RBCN;VCLK;VRTX;SYRG;PFE;ABBV;FIO;MLNX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | all recent news | >>
October 14, 2014
06:36 EDTGOOG'Double Irish' tax arrangement poised to halt, itnews says
Ireland is positioned to enact legal revisions soon that will slowly cease its "Double Irish" tax agreement, which has allowed companies like Google (GOOG) and Apple (AAPL) to not spend billions of dollars worth of taxes, according to itnews, citing, two sources familiar with the situation. Reference Link
06:19 EDTGOOGGoogle expands Express delivery service, to charge membership fee
Subscribe for More Information
06:02 EDTGOOGGoogle may be leading $500M funding round for Magic Leap, Re/code reports
Subscribe for More Information
October 13, 2014
15:06 EDTGOOGGoogle confirms limited test of online medical advice, Washington Post reports
Subscribe for More Information
13:53 EDTGOOGYouTube to open New York video production studio
Google's YouTube announced that it would open a new video production studio in New York next month. YouTube already has video production facilities in London, Los Angeles and Tokyo.
13:10 EDTGOOGGoogle's Schmidt says Amazon is company's biggest search rival, FT reports
Eric Schmidt, the executive chairman of Google (GOOG), says Amazon (AMZN) is his company's biggest rival in search, not Bing (MSFT) or Yahoo (YHOO), the Financial Times reports. Schmidt also argued in Berlin that Google should not be regulated "as if it were the gatekeeper of the internet," given the influence of Amazon and Facebook (FB). Reference Link
10:08 EDTVRTXOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:53 EDTRBCNRubicon shares undervalued, says Dougherty
Dougherty said Rubicon continues to sampling its rectangular shaped sapphire blocks with several smartphone OEM manufacturers and is well positioned if this market segment takes off. The firm views shares as undervalued and reiterates its Buy rating and $11 price target.
09:23 EDTVRTXVertex price target raised to $131 from $119 at RW Baird
Subscribe for More Information
09:23 EDTABBVAbbVie's Humira for hidradenitis suppurativa meets Phase 3 trial endpoint
AbbVie announced new results from PIONEER II, a pivotal Phase 3 study, demonstrating the effect of Humira in reducing common clinical signs and symptoms in moderate-to-severe hidradenitis suppurativa, specifically the number of abscesses and inflammatory nodules. The results of this study, in combination with previously presented results from PIONEER I, will contribute to worldwide regulatory filings for an expanded use of Humira, which is not currently approved by regulatory authorities for the treatment of HS.
08:06 EDTGOOGQihoo 360 launches ad exchange platform, Marbridge Daily reports
Subscribe for More Information
08:01 EDTPFEPfizer announces FDA acceptance of Palbociclib NDA with priority review
Subscribe for More Information
07:57 EDTGOOGGoogle price target lowered to $650 from $685 at Cowen
Subscribe for More Information
07:53 EDTGOOGYouTube changes have diffused much of tension with copyright holders, FT says
YouTube, which implemented Content ID in 2007 to help producers manage their rights and generate revenues from copyright-infringing content, has hit $1B in payments to companies that participate in the program and Fred von Lohmann, legal director for copyright at Google, credits the program for diffusing much of the tension the site previously had with copyright holders, reported Financial Times. Via Content ID, copyright owners can “monetize” their content by allowing ads to be sold against it or have the video blocked and taken down and von Lohmann told Financial Times that the "vast majority" choose to monetize. Reference Link
07:39 EDTABBVPharmaceutical Care Management Association to hold annual meeting
Subscribe for More Information
07:37 EDTABBVAmerican Society of Anesthesiologists to hold annual meeting
Subscribe for More Information
07:22 EDTGOOGSony/ATV could ditch licensing firms due to streaming dollars, NY Post reports
Sony/ATV Music Publishing (SNE) is considering no longer dealing with performance rights groups BMI and ASCP, and instead negotiating directly with online music services like Pandora (P), YouTube (GOOG) and Spotify due to outdated rules and low royalties, the New York Post reports. Reference Link
06:44 EDTGOOGGoogle testing feature that allows video chats with doctors, Engadget reports
Subscribe for More Information
06:44 EDTGOOGGoogle could announce new Nexus tablet on October 15, 9to5Google reports
Google's new Nexus tablet may be announced on Wednesday, October 15, 9to5Google reports, citing Bright Side of News. The HTC-made tablet is rumored to cost $400. Reference Link
05:35 EDTVRTXVertex upgraded to Overweight from Neutral at Piper Jaffray
Piper Jaffray upgraded Vertex Pharmaceuticals to Overweight citing likely approval of the company's Kalydeco plus lumacaftor combination next year. Piper expects Vertex's Cystic Fibrosis sales to grow to $3.1B in 2016 and raised its price target for shares to $125 from $87.50.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use